ArticlePharmaceuticals (Basel, Switzerland)2024

Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies.

Jędrzej Borowczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.